News

Gladstone in the News January 12, 2024

‘Striking’ Study Reveals Immune System Anomalies in People with Long COVID

San Francisco Chronicle—At least 10 percent of those who survive COVID continue to face debilitating symptoms months after the acute infection resolves. New research from the laboratory of Gladstone Senior Investigator Nadia Roan shows that individuals suffering Long Covid have a dysregulated immune response to the virus and evidence of T cell exhaustion, which may be due to the virus persisting within their bodies.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Article January 11, 2024

In Patients with Long COVID, Immune Cells Don’t Follow the Rules

Scientists at Gladstone Institutes and UC San Francisco analyzed immune cells in people with and without long COVID, making significant discoveries that will help answer questions about what causes the condition and how to treat it

News Release Research (Publication) COVID-19 Infectious Disease Roan Lab

Article December 11, 2023

Reflections on a Pandemic: 6 Questions with Melanie Ott

Melanie Ott, director of the Gladstone Institute of Virology, reflects on the breakthroughs driven by the COVID-19 pandemic and explains why virologists’ work is never done

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News November 23, 2023

Inside Long COVID’s War on the Body: Researchers Are Trying to Find Out Whether the Virus Has the Potential to Cause Cancer

Fortune—Researchers are investigating the possibility that people who suffer from Long COVID might be at elevated risk of developing cancer. Melanie Ott, director of the Gladstone Institute of Virology, explains that viruses related to SARS-CoV-2 have been shown to inactivate oncosuppressor proteins, which may predispose patients to cancer.

Gladstone Experts Cancer COVID-19 Infectious Disease Ott Lab

Article July 10, 2023

How Understanding RNA Structure Can Help Researchers Design Better HIV Drugs

New research sheds light on the biological effect of the many possible three-dimensional structures of a critical loop of RNA in HIV

Research (Publication) HIV/AIDS Infectious Disease Ott Lab

Gladstone in the News May 26, 2023

Fall’s COVID Shots May Be Different in One Key Way

The Atlantic—The next generation of COVID vaccines may be directed against just one lineage of the Omicron strain. Melanie Ott, director of the Gladstone Institute of Virology, explains why that could be a smart strategy to elicit a strong immune response.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News May 3, 2023

Should I Bother Getting a Bivalent COVID Booster Now?

San Francisco Chronicle—Gladstone Senior Investigator Nadia Roan explains that while prior vaccination or exposure to COVID-19 may confer long-term protection against serious disease, a booster shot with the bivalent vaccine will protect you for a few months against new infection.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Video April 20, 2023

40 Years of HIV Research: Celebrating the Career of Virologist Warner Greene

Colleagues look back on Warner Greene's 40 year career

Gladstone Experts History HIV/AIDS Infectious Disease Greene Lab

Article December 16, 2022

Tips from Virologists to Face the “Tripledemic” This Holiday Season

Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter

Gladstone Experts COVID-19 Infectious Disease Greene Lab Ott Lab Roan Lab

Gladstone in the News December 10, 2022

New COVID Subvariants Are ‘the Most Immune Evasive Yet.’ Here’s What That Means

San Francisco Chronicle—New SARS-CoV-2 subvariants are driving an increase in COVID case numbers around the world. Gladstone Investigator Nadia Roan explains that the subvariants have mutations that help them evade neutralizing antibodies, but stresses that getting the bivalent vaccine can still help strengthen immunity to the ever-changing virus.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Article December 9, 2022

Top Stories of 2022

Revisit some of Gladstone’s most important stories from the past year

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Genomic Immunology Neurological Disease Infectious Disease

Gladstone in the News December 2, 2022

Time to Wear a Mask Again? Here’s What Bay Area Health Experts Say amid Rising COVID Cases

San Francisco Chronicle—Although requirements for mask wearing and social distancing have eased around the country, a third winter of the pandemic is looming. Gladstone Senior Investigator Warner Greene recommends paying attention to local trends in case numbers to decide which COVID-19 precautions to take.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News November 17, 2022

‟Swarm” of Variants Is Driving up California COVID Cases. Is This the Start of the Next Surge?

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, shares his views on the likelihood of a new COVID surge this winter.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News November 15, 2022

InvisiShield Technologies Announces the Appointment of Warner C. Greene, MD, PhD as President and Chief Scientific Officer

Invisishield Technologies—Gladstone Senior Investigator Warner Greene has been appointed President and Chief Scientific Officer of Invisihield Technologies. Invisishield is focused on developing intranasal preventatives for respiratory viruses, including SARS-CoV-2.

Gladstone Experts COVID-19 Infectious Disease Greene Lab

Gladstone in the News October 20, 2022

Scientists Explain What We Should Expect as COVID Variants Xbb, Bq.1 Spread in Europe, Asia

ABC7 News—Senior Investigator Nadia Roan, PhD, says that a winter surge of infections from the highly transmissible new variants of SARS-CoV-2 currently emerging in the US is likely, but it remains unclear how bad it will be.

Gladstone Experts COVID-19 Infectious Disease Roan Lab